KRYSTAL BIOTECH INC's ticker is KRYS and the CUSIP is 501147102. A total of 153 filers reported holding KRYSTAL BIOTECH INC in Q3 2022. The put-call ratio across all filers is 3.48 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $8,714,616 | +335.2% | 75,126 | +340.5% | 0.00% | +200.0% |
| Q2 2023 | $2,002,257 | +3.7% | 17,055 | -29.2% | 0.00% | 0.0% |
| Q1 2023 | $1,929,926 | +552.0% | 24,106 | +434.6% | 0.00% | – |
| Q2 2022 | $296,000 | -89.3% | 4,509 | -89.2% | 0.00% | – |
| Q1 2022 | $2,777,000 | -60.2% | 41,727 | -58.2% | 0.00% | -100.0% |
| Q4 2021 | $6,986,000 | +289.0% | 99,884 | +190.4% | 0.00% | +100.0% |
| Q3 2021 | $1,796,000 | +187.8% | 34,400 | +230.6% | 0.00% | – |
| Q4 2020 | $624,000 | +52.2% | 10,406 | +5.1% | 0.00% | – |
| Q2 2020 | $410,000 | +70.1% | 9,900 | +42.7% | 0.00% | – |
| Q3 2019 | $241,000 | – | 6,939 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Redmile Group, LLC | 1,913,280 | $153,177,197 | 6.65% |
| Frazier Life Sciences Management, L.P. | 945,407 | $75,689,284 | 5.48% |
| S Squared Technology, LLC | 108,215 | $8,663,693 | 5.14% |
| Nicholas Investment Partners, LP | 374,718 | $29,999,923 | 2.28% |
| Avoro Capital Advisors LLC | 1,750,000 | $140,105,000 | 2.08% |
| Artal Group S.A. | 412,082 | $32,991 | 1.96% |
| First Light Asset Management, LLC | 195,980 | $15,690,159 | 1.41% |
| Integral Health Asset Management, LLC | 85,000 | $6,805,100 | 1.37% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 61,000 | $4,883,660 | 1.36% |
| Hood River Capital Management LLC | 447,393 | $35,818,000 | 1.16% |